DeepMed Research

UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Clofarabine, Cytarabine, and G-CSF in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase 1

Completed

Conditions: Acute Myeloid Leukemia
Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
Adult Acute Promyelocytic Leukemia (M3)
Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)
Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)
Recurrent Adult Acute Myeloid Leukemia

Interventions: Drug: clofarabine
Drug: cytarabine
Biological: filgrastim

First Posted Date: 2008-01-28

Last Posted Date: 2018-03-09

Lead Sponsor: University of Washington

Target Recruit Count: 50

Registration Number: NCT00602225

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

ACY-7 Oral Administration of Acyline

Phase 1

Completed

Conditions: Healthy

First Posted Date: 2008-01-28

Last Posted Date: 2011-06-09

Lead Sponsor: University of Washington

Target Recruit Count: 4

Registration Number: NCT00603187

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Project to Improve Symptoms and Mood in People With Spinal Cord Injury

Phase 4

Completed

Conditions: Spinal Cord Injuries
Major Depressive Disorder
Dysthymia

Interventions: Drug: venlafaxine XR
Drug: placebo

First Posted Date: 2008-01-14

Last Posted Date: 2015-01-01

Lead Sponsor: University of Washington

Target Recruit Count: 133

Registration Number: NCT00592384

Locations: 🇺🇸
University of Miami, Miami, Florida, United States
🇺🇸
University of Alabama, Birmingham, Alabama, United States
🇺🇸
Rehabilitation Institute of Chicago, Chicago, Illinois, United States

and more 3 locations

Interpersonal and Social Rhythm Therapy for Adolescents With Bipolar Disorder

Not Applicable

Completed

Conditions: Bipolar Disorder

Interventions: Behavioral: Treatment As Usual (TAU)
Behavioral: Interpersonal and Social Rhythm Therapy for Adolescents (IPSRT-A)

First Posted Date: 2007-12-19

Last Posted Date: 2012-06-20

Lead Sponsor: University of Washington

Target Recruit Count: 36

Registration Number: NCT00576355

Locations: 🇺🇸
Seattle Children's Hospital, Seattle, Washington, United States

Stimulant Abuser Groups to Engage in 12-Step

Phase 3

Completed

Conditions: Drug Abuse

Interventions: Behavioral: STAGE-12
Behavioral: Treatment as Usual

First Posted Date: 2007-12-14

Last Posted Date: 2016-12-05

Lead Sponsor: University of Washington

Target Recruit Count: 471

Registration Number: NCT00573183

Locations: 🇺🇸
Gateway Community Services, Jacksonville, Florida, United States
🇺🇸
ChangePoint, Inc., Portland, Oregon, United States
🇺🇸
Recovery Centers of King County, Seattle, Washington, United States

and more 7 locations

Analyzing Gene Regions That May Interact With the Effectiveness of High Blood Pressure Drugs

Withdrawn

Conditions: Death, Sudden, Cardiac
Cerebrovascular Accident
Myocardial Infarction

First Posted Date: 2007-12-13

Last Posted Date: 2016-11-09

Lead Sponsor: University of Washington

Registration Number: NCT00573092

Locations: 🇺🇸
Cardiovascular Health Research Unit, Seattle, Washington, United States

The Effect of Exercise on Mood After Traumatic Brain Injury

Not Applicable

Completed

Conditions: Depression
Traumatic Brain Injury

Interventions: Behavioral: Aerobic exercise
Behavioral: No exercise

First Posted Date: 2007-12-12

Last Posted Date: 2017-02-06

Lead Sponsor: University of Washington

Target Recruit Count: 78

Registration Number: NCT00571545

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer

Phase 2

Completed

Conditions: Malignant Pleural Effusion
Stage IIIB Non-small Cell Lung Cancer
Stage IV Non-small Cell Lung Cancer

Interventions: Drug: carboplatin
Drug: docetaxel
Drug: gemcitabine hydrochloride
Drug: paclitaxel
Procedure: computed tomography
Procedure: positron emission tomography
Radiation: fludeoxyglucose F 18
Other: imaging biomarker analysis

First Posted Date: 2007-11-28

Last Posted Date: 2017-02-10

Lead Sponsor: University of Washington

Target Recruit Count: 55

Registration Number: NCT00564733

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
🇺🇸
Harborview Medical Center, Seattle, Washington, United States

Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples

Phase 3

Completed

Conditions: HIV-1 Infections
HIV Infections

Interventions: Drug: Tenofovir Disoproxil Fumarate (TDF)
Drug: Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF)
Drug: Placebo

First Posted Date: 2007-11-12

Last Posted Date: 2019-04-19

Lead Sponsor: University of Washington

Target Recruit Count: 4758

Registration Number: NCT00557245

Locations: 🇺🇬
The AIDS Support Organization - Tororo Field Station, Tororo, Uganda
🇺🇬
Kabwohe Clinical Research Center, Bushenyi, Uganda
🇰🇪
Partners in Prevention - Thika, Thika, Kenya

and more 6 locations

Randomized Controlled Trial of Vitamin D3 in Diabetic Kidney Disease

Phase 2

Completed

Conditions: Diabetes Mellitus
Chronic Kidney Disease
Diabetic Kidney Disease

Interventions: Dietary Supplement: Cholecalciferol
Dietary Supplement: Placebo

First Posted Date: 2007-11-01

Last Posted Date: 2014-04-28

Lead Sponsor: University of Washington

Target Recruit Count: 22

Registration Number: NCT00552409

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy